Bent Frandsen

Vorstandsvorsitzender bei EXPRES2ION BIOTECH HOLDING AB

Health Technology

Consumer Services

Profil

Bent U.
Frandsen currently works at ExpreS2ion Biotechnologies ApS, as Chief Executive Officer and Expres2ion Biotech Holding AB, as Chief Executive Officer from 2019.
Mr. Frandsen also formerly worked at Adaptvac ApS, as Director and NsGene A, as Vice President-Business Development.
Mr. Frandsen received his graduate degree in 1993 from Copenhagen Business School.

Aktive Positionen von Bent Frandsen

Unternehmen	Position	Beginn
EXPRES2ION BIOTECH HOLDING AB	Vorstandsvorsitzender	20.12.2019
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Vorstandsvorsitzender	-

Alle aktiven Positionen von Bent Frandsen

Ehemalige bekannte Positionen von Bent Frandsen

Unternehmen	Position	Ende
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders	Corporate Officer/Principal	-
Adaptvac ApS Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Bent Frandsen im Detail an

Ausbildung von Bent Frandsen

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Bent Frandsen im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
Copenhagen Business School Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders	Health Technology
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Health Technology
Expres2ion Biotech Holding AB Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer	Health Technology
Adaptvac ApS Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Health Technology